Alessio Ardizzone
Overview
Explore the profile of Alessio Ardizzone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Crupi L, Ardizzone A, Calapai F, Scuderi S, Benedetto F, Esposito E, et al.
Diseases
. 2024 Apr;
12(4).
PMID: 38667532
Since the inception of the SARS-CoV-2 pandemic, healthcare systems around the world observed an increased rate of Acute Limb Ischemia (ALI) in patients with a COVID-19 infection. Despite several pieces...
12.
Repici A, Ardizzone A, Luca F, Colarossi L, Prestifilippo A, Pizzino G, et al.
Cells
. 2024 Feb;
13(4.
PMID: 38391974
Brain tumors are a diverse collection of neoplasms affecting the brain with a high prevalence rate in people of all ages around the globe. In this pathological context, glioblastoma, a...
13.
Ardizzone A, Mannino D, Casili G, Campolo M, Paterniti I, Lanza M, et al.
Phytother Res
. 2024 Jan;
38(3):1610-1622.
PMID: 38296262
Gastroesophageal reflux disease (GERD) is the most common foregut disease, affecting about 20% of the adult population. Esophageal epithelial barrier plays a fundamental role in the pathophysiology of GERD; however,...
14.
Crupi L, Capra A, Paterniti I, Lanza M, Calapai F, Cuzzocrea S, et al.
Nat Prod Res
. 2024 Jan;
39(4):797-816.
PMID: 38269580
Intraocular pressure (IOP) positively correlates with both normal and high-tension glaucoma. To date, IOP targeting remains the validated pharmacological approach in counteracting glaucoma progression as well as in halting vision...
15.
Ardizzone A, Capra A, Repici A, Lanza M, Bova V, Palermo N, et al.
Free Radic Biol Med
. 2024 Jan;
213:65-78.
PMID: 38244728
Migraine is one of the most common neurological illnesses, and it is characterized by complicated neurobiology. It was confirmed the influence of inflammation and oxidative stress in migraines and also...
16.
Ardizzone A, Bova V, Casili G, Filippone A, Lanza M, Repici A, et al.
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834102
A spinal cord injury (SCI) is a well-defined debilitating traumatic event to the spinal cord that usually triggers permanent changes in motor, sensory, and autonomic functions. Injured tissue becomes susceptible...
17.
Capra A, Crupi L, Panto G, Repici A, Calapai F, Squeri R, et al.
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762499
Currently, biological markers for COVID-19 disease severity still constitute the main goal of enhancing an efficient treatment to reduce critical consequences such as an abnormal systemic inflammatory response. In this...
18.
Repici A, Ardizzone A, Filippone A, Colarossi C, Mare M, Raciti G, et al.
Cells
. 2023 Sep;
12(18).
PMID: 37759505
Brain tumors represent a heterogeneous group of neoplasms involving the brain or nearby tissues, affecting populations of all ages with a high incidence worldwide. Among the primary brain tumors, the...
19.
Capra A, Ardizzone A, Crupi L, Calapai F, Campolo M, Cuzzocrea S, et al.
Biomedicines
. 2023 Aug;
11(8).
PMID: 37626685
Post-Covid Olfactory Dysfunction (PCOD) is characterized by olfactory abnormalities, hyposmia, and anosmia, which are among the most often enduring symptoms in individuals who have recovered from SARS-CoV-2 infection. This disorder...
20.
Ardizzone A, Repici A, Capra A, De Gaetano F, Bova V, Casili G, et al.
Antioxidants (Basel)
. 2023 Jun;
12(6).
PMID: 37372008
Atopic dermatitis (AD) is the most common chronically relapsing inflammatory skin disease, predominantly common in children; it is characterized by an eczematous pattern generally referable to skin dryness and itchy...